Takeda Eyes Further Filings For Dengue Vaccine But Timings Unclear
FDA Priority Review Granted
With Qdenga’s US approval process moving ahead with the granting of a Priority Review and the dengue vaccine's first market launch, in Indonesia, expected early next year, Takeda has recently referred to plans to expand the product into other countries as well. But precise timings as yet remain unclear.
